1-(tert-Butyl)-6,7-dihydro-1H-pyrazolo[4,3-c]pyridin-4(5H)-one
97%
- Product Code: 39572
CAS:
1257403-88-5
| Molecular Weight: | 193.25 g./mol | Molecular Formula: | C₁₀H₁₅N₃O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD24616746 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, dry and sealed |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of biologically active molecules. It serves as a building block for developing potential therapeutic agents, particularly in the design of inhibitors targeting specific enzymes or receptors. Its structural framework is often incorporated into compounds being studied for their anti-inflammatory, anticancer, or neurological activity. Researchers leverage its unique heterocyclic core to optimize drug-like properties, such as bioavailability and selectivity, in early-stage drug discovery programs. Additionally, it may be explored in the development of novel pharmaceuticals for treating conditions like autoimmune diseases or neurodegenerative disorders.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | £121.11 |
+
-
|
| 0.250 | 10-20 days | £190.93 |
+
-
|
| 1.000 | 10-20 days | £479.37 |
+
-
|
1-(tert-Butyl)-6,7-dihydro-1H-pyrazolo[4,3-c]pyridin-4(5H)-one
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of biologically active molecules. It serves as a building block for developing potential therapeutic agents, particularly in the design of inhibitors targeting specific enzymes or receptors. Its structural framework is often incorporated into compounds being studied for their anti-inflammatory, anticancer, or neurological activity. Researchers leverage its unique heterocyclic core to optimize drug-like properties, such as bioavailability and selectivity, in early-stage drug discovery programs. Additionally, it may be explored in the development of novel pharmaceuticals for treating conditions like autoimmune diseases or neurodegenerative disorders.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :